Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Classifica tra le azioni #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Prezzo delle azioni
$0.6
Ultima sincronizzazione: 2024-08-14
Capitalizzazione di mercato
$2.09M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
SG
Scambia ASLAN Pharmaceuticals Limited (ASLN)

Categoria

Cronologia dei frazionamenti azionari per ASLAN Pharmaceuticals Limited (ASLN)
L’azione ASLAN Pharmaceuticals Limited (simbolo: ASLN) ha subito un totale di 2 frazionamenti.
L’ultimo frazionamento è avvenuto il Jul 03, 2024.
Una quota di ASLN acquistata prima di Mar 13, 2023 equivale oggi a 0.025 quote di ASLN.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
2024-07-03 1:8 x0.125 x0.025
2023-03-13 1:5 x0.2 x0.2
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE